Answers are grounded in this paper and cite their sources.
The Internet of Medical Things (IoMT) is increasingly used in connected homes, where health-related devices may share networks and infrastructure with consumer Internet of Things (IoT) devices. Matter is a consumer IoT standard focusing on interoperability and technical security, while U.S. Food and Drug Administration (FDA) oversight addresses medical device safety and effectiveness. Understanding how users perceive the associated design trade-offs is important for developing trustworthy home IoMT systems. We conducted qualitative, scenario-based interviews with 40 participants (20 aged 18–30 and 20 aged 60+), whose self-reported device use included consumer wellness and medical monitoring devices. Participants considered hypothetical trade-offs involving software update speed and validation, continuous versus local-first connectivity, and smart-home integration. Their responses emphasized device accuracy, transparency, and meaningful user control. Participants distinguished routine updates from safety-critical changes, considered connectivity in relation to privacy and clinical needs, and weighed the emergency benefits of integration against household security risks. Preferences depended on the perceived consequences and circumstances of each scenario rather than consistently favoring one design approach. These findings provide qualitative insights into user expectations and suggest directions for clearer update information, configurable connectivity, and selective integration that warrant further evaluation.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: